•
Sep 30, 2012

Corcept Therapeutics Q3 2012 Earnings Report

Total Revenue
$1.06M
EPS
-$0.08
Previous year: -$0.08
+0.0%
Gross Profit
$1.03M
0

Corcept Therapeutics

Corcept Therapeutics